JASON KRAEMER: Open Payments
NPI 1811970189 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 70 payments from 17 companies in 2025. Trend: 2023 $1,097 · 2024 $1,842 · 2025 $1,501
Food & beverage: $1,317Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $242 |
| UCB, Inc. | 8 | $198 |
| Regeneron Healthcare Solutions, Inc. | 8 | $197 |
| GENZYME CORPORATION | 8 | $176 |
| ABBVIE INC. | 9 | $168 |
| Organon LLC | 9 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Lilly USA, LLC | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, Sotyktu, RINVOQ, VTAMA, TALTZ.
Industry payments across CO — which companies pay providers there.
